Peptide-based vaccination for colorectal cancer (Q36161221)

https://api.crossref.org/works/10.1517%2F14712598.5.6.799

The dendritic cell system and its role in immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.799

Manipulation of costimulatory signals to enhance antitumor T-cell responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.799

Presentation of exogenous antigen with class I major histocompatibility complex molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.799

A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.799

Helper T-cell subsets: phenotype, function and the role of lymphokines in regulating their development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.799

Phase I clinical study of anti-apoptosis protein, survivin-derived peptide vaccine therapy for patients with advanced or recurrent colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.799

The spontaneous CD8+ T-cell response to HLA-A2-restricted NY-ESO-1b peptide in hepatocellular carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.799

Enumerating antigen-specific T-cell responses in peripheral blood: a comparison of peptide MHC Tetramer, ELISpot, and intracellular cytokine analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.799

A shift in the phenotype of melan-A-specific CTL identifies melanoma patients with an active tumor-specific immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.799

Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.799

Immunotherapy of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.799

A novel cancer vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein: report of a pilot clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.799

A phase I trial of cytotoxic T-lymphocyte precursor-oriented peptide vaccines for colorectal carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.799

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.799

Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.799

A potent immunogenic general cancer vaccine that targets survivin, an inhibitor of apoptosis proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.799

Peptide vaccination after repeated resection of metastases can induce a prolonged relapse-free interval in melanoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.799

Immunotherapy as part of combinations for the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.799

release_brydqpnmwbbi3mku6gtpveqx3q

21 January 2018

Identifiers

DOI

10.1517/14712598.5.6.799

1 reference

12 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/brydqpnmwbbi3mku6gtpveqx3q